Investors must view Thursday’s market pullback ‘as a gift’
CNBC’s Jim Cramer on Thursday identified a number of food and drug stocks that are worth buying after the major indexes pulled back during the trading day. The “Mad Money” host recommended drug stocks Bristol-Myers Squibb, Merck, Eli Lilly, Biogen and Abbott Laboratories as buys on the way down. HeRead More →